e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Novel and old entities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Detrended Fluctuation Analysis independently predicts all-cause mortality of patients with Sarcoidosis
E. Gialafos (Athens Attiki, Greece)
Source:
International Congress 2017 – Novel and old entities
Session:
Novel and old entities
Session type:
Thematic Poster
Number:
3843
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Gialafos (Athens Attiki, Greece). Detrended Fluctuation Analysis independently predicts all-cause mortality of patients with Sarcoidosis. 3843
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality
Source: Eur Respir J 2010; 36: 1002-1006
Year: 2010
Predictor factors of mortality in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 808s
Year: 2006
Effect of Multiple Comorbidities on Mortality in COPD
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021
Analysis of NEWS2 trend to predict risk of death in COPD
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
Copeptin predicts all-cause mortality in stable COPD: An analysis of the COSYCONET study
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
Impact on in-hospital mortality of Ceftaroline versus standard of care in Community-Acquired Pneumonia: A Propensity Matched Analysis
Source: Virtual Congress 2021 – Pneumonia
Year: 2021
Analysis of the risk factors related to in-hospital deaths in patients with tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 504s
Year: 2006
Survival predictors of severe community-acquired pneumonia (CAP): Multivariate analysis of immunological and inflammatory parameters
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Late Breaking Abstract - High-sensitivity troponin I predicts all-cause mortality in stable COPD in the COSYCONET cohort
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018
Predictors of 30-day mortality in elderly patients with community acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Hematological parameters- as mortality predictors in COVID-19 patients
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021
Patient pathway modelling using Discrete Event Simulation to reduce readmissions in COPD
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Meta-analysis of FEV1 as a risk factor for all-cause mortality
Source: Eur Respir J 2003; 22: Suppl. 45, 484s
Year: 2003
High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study
Source: Eur Respir J, 55 (2) 1901314; 10.1183/13993003.01314-2019
Year: 2020
Prognostic power of biomarkers to predict in-hospital and postdischarge mortality in community acquired pneumonia
Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura
Year: 2013
Factors associated with prolonged duration of AECOPD:Analysis of the ECLIPSE cohort
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Survival characteristics and predictors of mortality in COPD subjects
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Predictors of mortality in COPD
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Predictors of mortality in COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept